Ralliant (NYSE:RAL) Upgraded at Zacks Research

Zacks Research upgraded shares of Ralliant (NYSE:RAL) from a strong sell rating to a hold rating in a research note published on Monday,Zacks.com reports.

Several other equities analysts have also issued reports on the company. Barclays dropped their price target on Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research note on Monday, February 9th. Royal Bank Of Canada dropped their price target on Ralliant from $52.00 to $41.00 and set a “sector perform” rating on the stock in a research note on Friday, February 6th. Citigroup dropped their price target on Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a research note on Friday, February 6th. Morgan Stanley reissued an “overweight” rating and issued a $45.00 price target on shares of Ralliant in a research note on Friday, February 6th. Finally, Vertical Research raised Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price target on the stock in a research note on Friday, February 6th. Seven equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $50.50.

Ralliant Price Performance

Ralliant stock opened at $45.71 on Monday. The stock’s 50 day moving average is $43.49 and its 200 day moving average is $46.75. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58. The firm has a market cap of $5.11 billion and a P/E ratio of 23.32. Ralliant has a one year low of $37.27 and a one year high of $57.02.

Ralliant (NYSE:RAL) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. The company had revenue of $554.60 million during the quarter, compared to analyst estimates of $543.04 million. The firm’s quarterly revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 23rd. Shareholders of record on Monday, March 9th were paid a $0.05 dividend. The ex-dividend date of this dividend was Monday, March 9th. This represents a $0.20 annualized dividend and a yield of 0.4%. Ralliant’s payout ratio is 10.20%.

Insider Activity at Ralliant

In other news, SVP Amir A. Kazmi bought 2,545 shares of the stock in a transaction dated Friday, February 6th. The shares were bought at an average cost of $39.27 per share, with a total value of $99,942.15. Following the completion of the transaction, the senior vice president directly owned 39,699 shares of the company’s stock, valued at $1,558,979.73. This trade represents a 6.85% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Kevin E. Bryant bought 1,250 shares of the stock in a transaction dated Friday, February 6th. The shares were purchased at an average cost of $39.97 per share, for a total transaction of $49,962.50. Following the completion of the transaction, the director directly owned 4,653 shares of the company’s stock, valued at $185,980.41. This trade represents a 36.73% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired 8,145 shares of company stock valued at $332,233 over the last three months.

Hedge Funds Weigh In On Ralliant

A number of institutional investors have recently modified their holdings of the company. Allworth Financial LP raised its position in shares of Ralliant by 134.4% during the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after purchasing an additional 293 shares during the period. Rothschild Investment LLC raised its position in shares of Ralliant by 98.1% during the fourth quarter. Rothschild Investment LLC now owns 612 shares of the company’s stock worth $31,000 after purchasing an additional 303 shares during the period. Keybank National Association OH raised its position in shares of Ralliant by 1.6% during the fourth quarter. Keybank National Association OH now owns 19,667 shares of the company’s stock worth $1,001,000 after purchasing an additional 305 shares during the period. UMB Bank n.a. raised its position in shares of Ralliant by 49.6% during the fourth quarter. UMB Bank n.a. now owns 983 shares of the company’s stock worth $50,000 after purchasing an additional 326 shares during the period. Finally, Maryland State Retirement & Pension System raised its position in shares of Ralliant by 1.5% during the fourth quarter. Maryland State Retirement & Pension System now owns 21,940 shares of the company’s stock worth $1,117,000 after purchasing an additional 329 shares during the period.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.